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Abstract
Background: Biomaterials are widely used to regenerate or substitute bone tissue. In order to evaluate their
potential use for clinical applications, these need to be tested and evaluated in vitro with cell culture models.
Frequently, immortalized osteoblastic cell lines are used in these studies. However, their uncontrolled proliferation
rate, phenotypic changes or aberrations in mitotic processes limits their use in long-term investigations. Recently,
we described a new pluripotent-like subpopulation of dental pulp stem cells derived from the third molars (DPPSC)
that shows genetic stability and shares some pluripotent characteristics with embryonic stem cells. In this study we
aim to describe the use of DPPSC to test biomaterials, since we believe that the biomaterial cues will be more
critical in order to enhance the differentiation of pluripotent stem cells.
Methods: The capacity of DPPSC to differentiate into osteogenic lineage was compared with human sarcoma
osteogenic cell line (SAOS-2). Collagen and titanium were used to assess the cell behavior in commonly used
biomaterials. The analyses were performed by flow cytometry, alkaline phosphatase and mineralization stains,
RT-PCR, immunohistochemistry, scanning electron microscopy, Western blot and enzymatic activity. Moreover, the
genetic stability was evaluated and compared before and after differentiation by short-comparative genomic
hybridization (sCGH).
Results: DPPSC showed excellent differentiation into osteogenic lineages expressing bone-related markers similar
to SAOS-2. When cells were cultured on biomaterials, DPPSC showed higher initial adhesion levels. Nevertheless,
their osteogenic differentiation showed similar trend among both cell types. Interestingly, only DPPSC maintained a
normal chromosomal dosage before and after differentiation on 2D monolayer and on biomaterials.
Conclusions: Taken together, these results promote the use of DPPSC as a new pluripotent-like cell model to
evaluate the biocompatibility and the differentiation capacity of biomaterials used in bone regeneration.
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Background
The increase in life expectancy has been associated with
a rise in the number of bone-grafting procedures for dis-
eases such as osteoporosis, arthritis, tumors and trauma;
placing an even larger demand on the healthcare system
to replace and restore bone loss [1]. Recently, a great
deal of efforts has focused in the field of bone tissue
engineering, and, particularly, in the area of stem cell
biology and how to modulate their behavior through
environmental cues [1].
Biomaterials have been shown to allow the guidance of
stem cells in vitro as well as in vivo. In order to assess
their biocompatibility as well as their ability to differenti-
ate cells into specific lineages, these need to be tested in
an in vitro cell culture model. For this purpose, many
established cell lines and models have emerged to ad-
dress the surge in research in this field [2]. For instance,
for bone related biomaterials, most studies have examined
their osteogenic potential using immature osteoblasts, im-
mortalized cell lines or mesenchymal stem cells among
others. Primary cells, such as lineage-specific osteoblasts,
can be isolated and cultivated relatively easily; however,
they have a limited lifespan [3]. Immortalized cell lines,
such as the human sarcoma osteogenic cell line (SAOS-2)
have been frequently used in applied biology since they
are from human origin while providing unlimited number
of cells [2, 4]. Nevertheless, these cell lines, due to their
cancer origin, usually possess phenotype changes between
passages, aberrations in mitotic processes and lack of
growth inhibition, which limits their use in long-term in-
vestigations [5]. On the other hand, mesenchymal stem
cells (MSC), which can be isolated from many adult tis-
sues, are an attractive cell source for tissue engineering.
These cells are self-renewable with a high proliferative
capacity and possess a multi-lineage differentiation poten-
tial [6]. However, long-term MSC culture conditions, for
their maintenance and expansion, cause morphological
and immune-phenotypical changes which lead to cell sen-
escence and alternations in their differentiation potential.
For example, morphological abnormalities, cellular en-
largement, miss expression of specific surface markers and
an ultimate growth inhibition are associated with MSC
that are cultured beyond passage 12 [7]. Therefore, there
is a need to find a cell type with genetic stability and stem-
ness characteristics to be used to evaluate biomaterials in
cell therapy applications.
The dental pulp is an accessible niche housing neural
crest-derived stem cells. This niche contains several
populations of dental pulp stem cells (DPSC), with
different properties. The first characterized population was
the dental pulp mesenchymal stem cells (DPMSC), with
multi-potential capability. Recently, a new stem cell popu-
lation from the human dental pulp of third molars has
been isolated. These cells, named dental pulp pluripotent-
like stem cells (DPPSC) have particular culture conditions
and, unlike DPMSC, express pluripotency markers until
late passages and are able to differentiate into cells from
the three germ layers (endoderm, mesoderm and ecto-
derm) [8, 9]. We therefore consider that DPPSC could be
a promising cell population that can be used to evaluate
the biological properties of biomaterials. The use of differ-
entiated cells, e.g. osteoblast cells, limits the relevance of
the biomaterial since it is already expected that the bioma-
terial will allow expression of osteogenic markers. For this
purpose, the use of pluripotent cells that can potentially
differentiate into any lineage can be properly guided by
the biomaterial and hence demonstrating the efficiency of
the biomaterial [10]. While this is the main purpose of
pluripotent stem cells, up to date, embryonic stem cells
and induced pluripotent stem cells (iPSC) have limited ap-
plications for biomaterials testing due to ethical reasons
or low efficient transfections [10]. Hence, DPPSC might
be used in order to overcome the current limitations of
specific cell lineages or other pluripotent stem cells.
One of the key objectives of bone tissue engineering is
the enhancement of stem cell mediated osteogenic
differentiation under three-dimensional (3D) scaffold con-
ditions to mimic engineering of clinically applicable bone
constructs [1, 11]. In this way, scaffolds provide suitable
support for cellular infiltration, migration, as well as,
proper cell proliferation and differentiation [12]. Scaffolds
are manufactured from several biomaterials including
metals, ceramics, synthetic polymers or natural polymers.
Currently, the components of the extracellular matrix play
an important role as natural substrates for in vitro cells in
cultures [13]. In this sense, collagen is regarded as an ideal
scaffold for tissue engineering, as it provides support to
connective tissues [14–16]. Collagen type I based mate-
rials are extensively used for basic cell culture applications,
as well as in the fields of bioreactor technology and tissue
engineering [17–19]. On the other hand, titanium and
titanium alloys are primarily used in bone implant mate-
rials. Titanium has been widely used in medical practice,
showing excellent biocompatibility and safety [20]. Hence,
tissue compatibility, osseointegration and functional
maintenance of functions are fundamental criteria for the
long-term success of endosseous dental implants [21].
Therefore, the main purpose of this study was to
assess the biocompatibility and the osteogenic capacity
of DPPSC in the presence of different types of biomate-
rials used in bone regeneration studies, such as metals
or natural scaffolds.
Methods
Patient selection and ethics statement
The third molars of healthy patients were extracted for
orthodontic reasons and 6 different patients of different
sexes and ages (14-21 years old) were selected.
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The procedure and all experiments of this study were
performed in accordance with the guidelines on human
stem cell research issued which was approved by the
Committee on Bioethics of the Universitat Internacional
de Catalunya, with the study code: BIO-ELB-2013-03.
Isolation of DPPSC and DPMSC from third molars
In this study, DPPSC and DPMSC were isolated from
the same dental pulps as previously described [22].
Briefly, the molars were cleaned using gauze soaked in
70% ethanol previously the extraction of the dental pulp.
Then, the dental pulp tissues were disaggregated by
digestion with collagenase type I (3 mg/ml; Sigma) for
60 min at 37 °C. After washing twice with DPBS (Sigma),
isolated cells were cultured in two different mediums
and densities in order to separate DPPSC from DPMSC.
DPPSC and DPMSC were maintained and expanded
under different culture conditions until passage 15.
Culture of DPPSC
The culture medium for DPPSC consisted of 60%
DMEM-low glucose (Life Technologies) and 40% MCDB-
201 (Sigma) supplemented with 1X SITE (Sigma), 1X LA-
BSA (Sigma), 10-4M ascorbic acid 2-phosphate (Sigma),
1% penicillin/streptomycin (Life Technologies), 2% FBS
(Biochrom), 10 ng/ml hPDGF-BB (R&D Systems) and
10 ng/ml EGF (R&D Systems). Flasks were pre-coated
with 100 ng/ml fibronectin for one hour at 37 °C in 5%
CO2 incubator. During the 2 weeks of primary culture,
the medium was changed every 4 days. Cells were pas-
saged when they were at 30% confluence by adding 0.25%
trypsin-EDTA (Life Technologies) and then they were cul-
tured at a density of 100 cells/cm2.
Culture of DPMSC
The culture medium for DPMSC consisted of DMEM-
high glucose (Life Technologies), 10% FBS (Biochrom)
and 1% penicillin/streptomycin (Life Technologies). The
medium was changed every 4 days during the first
2 weeks of primary culture. To propagate DPMSC, cells
were detached at 80% confluence by the addition of
0.25% trypsin-EDTA (Life Technologies) and reseeded at
a density of 2x103 cells/cm2.
Culture of SAOS-2
The commercially available SAOS-2 cells at passage 10
(Sigma) were seeded at density of 103cells/cm2 in
DMEM-high glucose (Life Technologies) supplemented
with 10% FBS (Biochrom), 2 mM L-glutamine and 1%
penicillin/streptomycin (Life Technologies), at 37 °C in a
5% CO2 incubator. The medium was changed every
3 days. After reaching 90% confluence, cells were
detached by the addition of 0.25% trypsin-EDTA (Life
Technologies).
Osteogenic differentiation on 2D
DPPSC isolated from three different patients at passages
1, 5 and 10 were osteogenetically stimulated for 21 days.
The osteogenic medium contained α −MEM (Gibco)
containing 10% heat-inactivated FBS (Biochrom),
10 mM β-glycerol phosphate (Sigma), 50 μM L-ascorbic
acid (Sigma), 0.01 μM Dexamethasone (Sigma) and 1%
penicillin/streptomycin (Life Technologies) solution.
Cells were cultured on 24 well culture plates at a cell
density of 5 × 103 cells/cm2. The cell line SAOS-2 were
used as a control and seeded at the same density. The
medium was changed every 2 days.
Osteogenic differentiation on biomaterials
In order to evaluate if DPPSC are appropriate to test the
osteogenic capacity of well-known biomaterials, DPPSC
from 2 of the same donors, used also in 2D differentia-
tions, were differentiated on biomaterials. The chosen
biomaterials, based on the extensive previous research
using different types of cells, were collagen I based cell
carriers (CCC) and titanium Ti6Al4V disks. The genetic
stability was evaluated by sCGH following each differen-
tiation step. A diagram of the experimental design is
provided in Fig. 1.
Collagen CCC
The CCC sheets (Viscofan Bio Engineering) were equili-
brated overnight in distilled water (200 μL per sheet) at
37 °C. The disks were transferred into 48-well plates pre-
loaded with distilled water. After the removal of residual
water, the culture plates containing the CCC sheets were
dried overnight at RT under sterile conditions in a Lam-
inar Air-Flow Cabinet. Before cell seeding, the dried CCC
sheets were equilibrated with culture medium for 10 min
at 37 °C. Due to the drying process, the collagen sheets
firmly attached to the plastic well without the entrapment
of air. Thus, cells could only adhere to the upper surface
of the CCC. DPPSC were seeded at a density of 5 × 103
cells/cm2 with osteogenic medium for 21 days. SAOS-2
cells were seeded and differentiated under the same condi-
tions as a control.
Ti6Al4V disks
Ti6Al4V disks were obtained by cutting commercially
available titanium alloy Ti6Al4V into 2.0-mm-thick disks
with a 14 mm diameter and, subsequently, the surface
was alumina-blasted and acid-etched to induce rough-
ness, thus increasing the surface area (provided by MIS
Implants Technologies Ltd.).
The osteogenic differentiation was performed on
Ti6Al4V disks in 24-well plates at a density of 5 × 103
cells/cm2 using osteogenic medium for 15 days.
For bone differentiation on titanium disks there are
two models (see Fig 1). The first one, coded TI DPPSC,
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consist on undifferentiated DPPSC seeded directly on
the disk surfaces. In the second model, coded as TI
B.DPPSC, before being seeded on disks, DPPSC were
differentiated for 15 days under 2D conditions, obtaining
bone-like DPPSC (B.DPPSC). These osteogenic-like cells
were then cultured on titanium disks and maintained
during 15 days more in osteogenic medium.
Immunohistochemistry
For DPPSC analysis, the cells were fixed with Cytofix
(BD Biosciences) for 1 h at room temperature and then
incubated with 1% Tween-20 for 30 min at room
temperature to increase cell permeability. The slides
were sequentially incubated overnight at 4 °C with pri-
mary antibodies against SSEA-4 (1:50, BD Pharmingen)
or OCT3/4 (1:50, BD Pharmingen) and then for 60 min
at 37 °C with PE-coupled anti-rabbit IgG and FITC-
coupled anti-mouse IgG (1:200, BD Pharmingen). For
differentiated DPPSC at day 21, primary antibodies
against osteocalcin (1:50, Millipore) and collagen IV
(1:100, Abcam) were used. Alexa 568 anti-rabbit IgG
(1:200, Life Technologies) and Alexa 488 anti-mouse
IgG (1:200, Santa Cruz Biotechnology) were used as
secondary antibodies, respectively. Between each step,
the slides were washed with Perm/Wash 1X (1:200, BD
Biosciences). The cells were examined by confocal fluor-
escence microscopy.
Flow cytometry
To confirm the phenotype of the undifferentiated
DPPSC, FACS analysis was performed. The following
fluorochrome labelled monoclonal antibodies were used:
CD105-FITC (R&D Systems), CD29-PE (R&D Systems),
CD146-FITC (BD Pharmingen), CD45-PE (BD Pharmin-
gen), NANOG-FITC and OCT3/4-FITC (R&D Systems).
To analyze the control samples, different IgG isotypes
coupled to PE and FITC fluorochromes (BD Pharmin-
gen) were used. The cells were suspended in PBS with
2% FBS and were incubated for 45 min at 4 °C in the
absence of light. Subsequently, the cells were washed
twice with 2% FBS-PBS and centrifuged for 6 min at
1800 rpm, thereby removing any residual fluorochrome
to avoid false positive results. The pellets were re-
suspended in volumes between 300 and 600 μl (depend-
ing on the number of cells) of PBS with 2% FBS. The
flow cytometry measurements were made using a FACS
cytometer (FACS Calibur, BD Biosciences) and analyzed
with WinMDI 2.8 software. To detect and exclude non-
specific unions and auto fluorescence, at least 5x105 cells
were used for each sample.
Fig. 1 Schematic diagram of the experimental design. a Osteogenic differentiation of DPPSC cultures. Undifferentiated DPPSC were cultivated
during 15 passages, from 6 different donors. The genetic stability was checked at passages 1, 5, 10 and 15 by sCGH. 2D osteogenic differentiation:
DPPSC from 3 of the 6 donors at P10 were differentiated during 21 days with osteogenic media in plastic culture plates. 3D osteogenic
differentiation: DPPSC from 2 of the same donors (at passages 1, 5 and 10) used also in 2D differentiation were differentiated on biomaterials
(CCC and Ti disks) during 21 and 15 days. DPPSC after 15 days of osteogenic 2D differentiation (B.DPPSC) were also seeded on titanium disks and
maintained during 15 days more in osteogenic medium (TI B.DPPSC). sCGH was performed in all DPPSC differentiations. b SAOS-2 at P10 were
used as a control cell line in all experiments. Genetic instability of SAOS-2 was evaluated before osteogenic induction experiments. DPPSC, Dental
pulp pluripotent stem cells; SAOS-2, human osteosarcoma cell line; B.DPPSC, Bone-like DPPSC, differentiated 15 days in 2D conditions; TI DPPSC, DPPSC
differentiated on titanium disks; TI B. DPPSC, Bone-like DPPSC differentiated on titanium disks; CCC, Collagen I-based Cell Carrier; TI disks, Ti6Al4V disks;
sCGH, short-chromosome genetic hybridization
Núñez-Toldrà et al. BMC Cell Biology  (2017) 18:21 Page 4 of 15
Western blot analysis
Total protein was extracted from undifferentiated
DPPSC at passages 5, 10 and 15 using Trizol Reagent
(Life Technologies) according to the manufacturer’s in-
structions. Protein quantification was performed using
Bradford Reagent (Sigma). Aliquots of cell lysates at a
concentration of 20 μg/μl were loaded on SDS-PAGE
using 12% polyacrylamide gels and transferred onto
nitrocellulose membranes. The membranes were then
blocked with 1% (wt/vol) BSA in PBS containing 0.1%
Tween-20. OCT3/4 and GAPDH primary antibodies
(1:500, Abcam) were then incubated with the membranes,
followed by washing and incubations with secondary anti-
bodies (1:5000, Abcam). The primary antibodies used
were anti-Osteocalcin (OC), anti-Osteopontin (OPN),
anti-Collagen I (COL1) and anti-GAPDH as housekeeping
(1:500, Abcam). The Western blot membrane was finally
developed using Luminata Forte Western HRP substrate
(Millipore).
Short-comparative genomic hybridization (sCGH)
The sCGH technique was performed as described in
Rius M. et al. [23] in triplicates of 12-14 cells from each
sample. Undifferentiated DPPSC at passages 1, 5, 10 and
15 from 6 different donors were analyzed. Differentiated
DPPSC in 2D conditions (well plates) were analyzed at
passages 1, 5 and 10 from 3 patients after 21 days of
osteogenic differentiation. Differentiated DPPSC, from 2
donors at passage 10, cultured on biomaterials (titanium
disks and collagen carrier) were evaluated after 21 days
of osteogenic differentiation.
SAOS-2 cells at passage 10 were analyzed before differ-
entiation under 2D and 3D conditions. A 47, XXY sample
was used to perform the hybridization of the controls and
samples. This procedure was performed by an external
service (Universitat Autònoma de Barcelona).
Alkaline phosphatase (ALP) staining
ALP was determined in undifferentiated DPPSC (day 0)
and after 3, 7, 15 and 21 days of DPPSC differentiation
by ALP staining Kit (CosmoBio) following the manufac-
turer’s instructions. Briefly, cells were fixed with 10%
Formalin Neutral Buffer Solution, for 20 min at RT.
After 3 washes with 1 ml of deionized water, 200 μl of
Chromogenic Substrate were added to each well and in-
cubated for 20 min at 37 °C. Finally, to stop the reaction,
the stainings were washed again with 1 ml of deionized
water and observed the obtained blue staining under an
optical microscope.
Von Kossa Staining
Mineralization was determined in undifferentiated
DPPSC (day 0) and after 3, 7, 15 and 21 days of DPPSC
differentiation by Von Kossa Method for Calcium
staining (Polysciences), following the manufacturer’s
protocol. Briefly, cells were fixed with 10% Formalin
Neutral Buffer Solution, for 20 min at RT and stained
with 0.5 ml of 3% Silver Nitrate Solution under UV light
for 45 min. After 3 washes with 0.5 ml of deionized
water, 0.5 ml of 5% sodium thiosulfate were added to
each well for 2 min at RT, and washed again with 1 ml
of deionized water 3 times. Finally, the samples were
counterstained in Nuclear Fast Red for 5 min at RT and
photographed with an optic microscope.
Alkaline phosphatase (ALP) activity
ALP activity was determined quantitatively in undiffer-
entiated DPPSC (day 0) and after 7 and 15 days of differ-
entiation in DPPSC, B. DPPSC and SAOS-2 cells on TI
disks. An ALP Kit (BioSystems) was used in accordance
with the manufacturer’s instructions. In short, the ALP
was measured by determining the velocity of the forma-
tion of 4-nitrophenol starting from 4-nitrophenol phos-
phate. In order to initiate the ALP enzyme reaction,
20 μl of each sample supernatant were added to 1 ml of
working solution containing 4:1 stock substrate solution
(4-nitrophenol phosphate) and buffer solution (1.2 M
diethanoloamine, 0.6 mM MgCl2). Finally, the absorb-
ance of each sample was measured at 405 nm during
4 min. The increase of the absorbance was calculated
with the average of absorbance per minute (ΔA/min).
Scanning electron microscopy (SEM)
SEM analysis of the biomaterials was performed prior to
differentiation and after DPPSC and SAOS-2 cells were
differentiated on the biomaterials. The samples were fixed
with 2.5% glutaraldehyde (Ted Pella Inc.) in 0.1 M Na-
cacodylate buffer (EMS, Electron Microscopy Sciences,
Hatfield, PA, USA) (pH 7.2) for 1 h on ice. After fixation,
the samples were treated with 1% osmium tetroxide
(OsO4) for 1 h. The samples were then dehydrated in ser-
ial solutions of acetone (30–100%) with the scaffolds
mounted on aluminum stubs. The samples were examined
with a Zeiss 940 DSM scanning electron microscope.
RNA isolation, RT-PCR and qRT-PCR
Total RNA from undifferentiated cells, 2D differentiated
cells (days 0, 7 and 21 days of differentiation) and differen-
tiated cells on the biomaterials at the end of differentiation
(day 21 in CCC and day 15 in Ti disks) was extracted by
Trizol Reagent (Life Technologies) following the manufac-
turer’s instructions. RNA aliquots of 2 μg were treated with
DNase I (Life Technologies) and reverse-transcribed using
a Transcription First Strand cDNA Synthesis Kit (Roche),
following the manufacturer’s instructions. PCR was per-
formed using the primers listed in Table 1 for the amplifi-
cation of OCT3/4, NANOG, SOX2, ALP, OC, COL1,
RUNX2, VLA4, VCAM1, ITGα3, ITG and GAPDH
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cDNAs. The resulting amplicons were resolved by agarose
gel electrophoresis. A human bone cDNA sample (Biocom-
pare) and SAOS-2 cells were used as a positive control.
Quantitative RT-PCR was performed using a CFX96
thermocycler (Bio-Rad). A total of 50 ng of cDNA of TI
DPPSC, TI B.DPPSC and TI SAOS-2 cells on Ti disks
was used. cDNA samples were amplified using specific
primers and SYBR Green Supermix (Bio-Rad Laborator-
ies, Inc.). The expression levels of the genes of interest
(OCT3/4, RUNX2, COL1, OC, VLA4, ITGα3 and
ITGαV) were normalized against the housekeeping gene
GAPDH. The relative expression levels were normalized
to day 0 of the DPPSC cDNAs in 2D differentiation or
with TI SAOS-2 cDNAs in titanium differentiation,
which were assigned as 1. All analyses were performed
using the 2-ΔΔCT method and 3 technical replicates.
Statistical analysis
Data from the osteogenic differentiation (qRT-PCR,
calcium quantification, ALP activity) of DPPSC on 2D
and titanium were analyzed by applying two-way analysis
of variance or ANOVA for multiple factors. Statistical ana-
lysis was performed using the SPSS 21.0 software package.
Confidence intervals were fixed at 95% (P < 0.05).
Results
Characterization of dental pulp pluripotent-like stem cells
DPPSC were isolated as a new subpopulation of DPSC
with pluripotent-like characteristics. They were expanded
and characterized as previously described [22]. The results
with their pluripotent-like characteristics during 15
culture passages comparing with DPMSC are shown in
Additional file 1: Figure S1.
2D Osteogenic differentiation
Under 2D conditions, the osteogenic differentiation of
DPPSC was investigated by examining the gene expres-
sion profile of pluripotent and osteogenic markers dur-
ing 21 days of culture in osteogenic medium (Fig. 2a-b).
Firstly, qRT-PCR analysis revealed a gradual decrease in
the expression of the pluripotency markers OCT3/4 and
NANOG during DPPSC differentiation (Fig. 2a). On the
other hand, the transcript expression of the early osteo-
genic marker RUNX2 was shown to increase and peaked
at day 7, showing notably lower expression at the end of
the differentiation. Then, the OC expression was up-
regulated reaching the highest levels at day 15 of differ-
entiation (Fig. 2b).
Moreover, RT-PCR results showed that the expression
levels of ALP and COL1 were pronouncedly increasing
until week 3 and confirmed that RUNX2 expression was
decreasing after first week of differentiation (Fig. 2c).
Finally, in order to summarize the genetic pattern during
the osteogenic differentiation of DPPSC, a schematic
representation with the different stages was performed
(Fig. 2d).
In addition, DPPSC morphology was examined by
optical microscopy along the osteogenic differentiation
Table 1 Primer pairs used to assess osteoblast differentiation in the RT-PCR and qRT-PCR amplification
Gene Accession number Forward primer (5′-3′) Reverse primer (5′-3′) Product size (bp) Use
OCT 3/4 NM_002701 GTGGAGAGCAACTCCGAT G TGCAGAGCTTTGATGTCCTG 122 RT-PCR
qRT-PCR
NANOG NM_024865 CAGAAGGCCTCAGCACCTAC ATTGTTCCAGGTCTGGTTGC 111 RT-PCR
qRT-PCR
ALP NM_000478 GGACATGCAGTACGAGCTGA GTCAATTCTGCCTCCTTCCA 133 RT-PCR
ALP NM_000478 CCGTGGCAACTCTATCTTTGG GCCATACAGGATGGCAGTGA 79 qRT-PCR
COL1 NM_000088 ACTGGTGAGACCTGCGTGTA CAGTCTGCTGGTCCATGTA 263 RT-PCR
COL1 NM_000088 CCCTGGAAAGAATGGAGATGAT ACTGAAACC TCTGTGTCCCTTCA 139 qRT-PCR
OC NM_199173 GTGCAGCCTTTGTGTCCAA GCTCACACACCTCCCTCCT 129 RT-PCR
OC NM_199173 AAGAGACCCAGGCGCTACC T AAC TCGTCACAGTCCGGATTG 110 qRT-PCR
RUNX2 NM_001146038 TTACTGTCATGGCGGGTAAC GGTTCCCGAGGTCCATCTA 220 RT-PCR
RUNX2 NM_001146038 AGCAAGGTTCAACGATCTGAGAT TTTGTGAAGACGGTTATGGTCAA 81 qRT-PCR
VLA4 NM_000885 CGAACCGATGGCTCCTAGTG CACGTCTGGCCGGGATT 115 RT-PCR
ITGα3 NM_002204 TCCGAGTCAATGTCCACAGA GCTGGGCTACCCTATTCCTC 88 RT-PCR
qRT-PCR
ITGαV NM_002210 CCTTGCTGCTCTTGGAAC TC ATTCTGTGGCTGTCGGAGAT 74 RT-PCR
qRT-PCR
GAPDH NM_002046 CTGGTAAAGTGGATATTGTTGCCAT TGGAATCATATTGGAACATGTAAACC 81 RT-PCR
qRT-PCR
OCT-3/4 octamer-binding transcription factor 4, Nanog Nanog homeobox, ALP alkaline phosphatase, COL1 type I collagen, OC osteocalcin, RUNX2 Runt-related pro-
tein 2, VLA-4 Integrin alpha4beta1, ITGα3 integrin alpha 3, ITGαV integrin, alpha V, GAPDH glyceraldehyde-3-phosphate dehydrogenase
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at different time points. At day 0, undifferentiated
DPPSC were small-sized cells with rounded morphology,
large nuclei and low cytoplasm content. By the second
week of differentiation DPPSC adopted an elongated
morphology and started to mineralize (Fig. 3a).
Furthermore, functional osteogenic activity was quali-
tatively detected at different time points. ALP activity
enhancement was clearly observed in a time dependent
manner over the differentiation process (Fig. 3b). More-
over, as a mineralization assay, von Kossa staining
Fig. 2 Stages of DPPSC osteogenic differentiation during 21 days. a Relative expression of pluripotency (OCT3/4, NANOG) markers during the
osteogenic differentiation of DPPSC versus DPPSC at Day 0 (dotted line). b Relative expression of osteogenic markers (RUNX2, OC) during the
osteogenic differentiation of DPPSC versus SAOS-2 cells differentiated over 21 days in osteogenic medium (dotted line). c RT-PCR for osteogenic
markers (ALP, OC, COL1, RUNX2) at days 0, 11 and 21 of differentiation. Bone cDNA was used as a positive control and GAPDH was used as a
housekeeping. d Proposed scheme for osteogenic DPPSC culture with recognizable stages of differentiation. *P < 0.05
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showed the development of red regions which were rich
in osteoid as well as, detected in brown, calcium phos-
phate depositions (Fig. 3c).
In order to corroborate the qRT-PCR results with the
levels of protein expressed and hence, to evaluate the
differentiation efficiency of DPPSC, the protein expression
of the osteogenic markers was analyzed by immunofluor-
escence and Western blot analyses. Immunofluorescence
analysis using specific anti- OC and Col IV antibodies
showed the expression of the OC localized in the cyto-
plasm and the formation of the extracellular collagen
matrix (Fig. 3d). In addition, higher protein expression of
OC, OPN and COL 1 was detected at day 21 comparable
to that observed in SAOS-2 cells (Fig. 3e).
Genetic stability
The genetic stability was checked in undifferentiated
DPPSC and during their differentiation into bone-like
tissue on culture plates and on biomaterials by sCGH.
Undifferentiated and differentiated DPPSC exhibited a
normal karyotype with no presence of any aneuploidy or
any chromosome structural alteration. Therefore, results
showed that DPPSC maintained the stability before and
after the differentiation process (Fig. 4a-d).
Moreover, sCGH confirmed a normal karyotype of
DPPSC cultured on CCC and Ti6Al4V disks after differen-
tiation (Fig. 4e-f). In contrast, SAOS-2 cells showed genetic
mutations in numerous chromosomes, probably due to
their carcinogenic origin (Additional file 2: Figure S2).
Osteogenic differentiation on Biomaterials
Osteogenic differentiation on Collagen I-based Cell
Carrier (CCC)
DPPSC were cultured on CCC and the differentiation
was induced for 21 days (Fig. 5). SEM was utilized to
visualize the scaffold/cells constructs and obtain a better
understanding of the cell morphology. CCC scaffolds
with the attached cells exhibited a dense microstructure.
The cells were well dispersed and attached, covering the
Fig. 3 Osteogenic capacity of DPPSC during 21 days. a Cell morphology of DPPSC observed with optic microscopy at days 0, 3, 7, 15 and 21
of osteogenic differentiation. b ALP activity observed with optic microscopy at days 0, 3, 7, 15 and 21 by an ALP staining (blue). c Images of
mineralitzation at days 0, 3, 7, 15 and 21 stained by the von Kossa method showing mineralized bone (brown) and osteoid, supporting tissue and
structures (red). d, e Osteogenic protein expression of DPPSC after 21 days. d Immunofluorescence analysis of DPPSC showing the expression of
Osteogenic markers at day 21 of differentiation. Hoechst (HT) as a nucleus control. Scale bars: 200 μm (a-c), 50 μm (d). e Western Blot analysis of
osteogenic markers at day 0 and 21 of differentiation. SAOS-2 cells were used as a positive control. GAPDH was used as a housekeeping control
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entire surface and penetrating inside the collagen scaf-
fold (Fig. 5a-b).
Moreover, SEM images showed an extra cellular matrix
formed by calcium phosphate depositions (Fig. 5c-d), also
confirmed by an atomic microanalysis; with the presence
of calcium and phosphorus ions, 0,43% and 3.16%,
respectively (Fig. 5e). In addition, RT-PCR analysis for
RNA extracted after the osteogenic induction, revealed an
enhancement of the osteogenic markers ALP, OC and
RUNX2 as well as adhesion markers, COL1, VCAM1 and
VLA4 (Fig. 5f) at similar levels to that of 2D- differenti-
ated DPPSC or SAOS-2 cells. In addition, immunohisto-
chemistry sections using specific OC and OPN antibodies
showed the presence of these important proteins implied
in the mineralization process (Fig. 5g-h).
Osteogenic differentiation on titanium alloy disks (TI disks)
DPPSC (TI DPPSC), 15 day bone-like DPPSC (TI
B.DPPSC) and SAOS-2 cells (TI SAOS-2) were cultivated
Fig. 4 Genetic stability of DPPSC, before and after osteogenic differentiation by sCGH analysis. a, b sCGH from undifferentiated DPPSC at
passages 1, 5, 10 and 15 (N = 6, XX and XY donors); a Fluorochromes image; b Fixed limits summary. c, d sCGH at day 21 of 2D osteogenic
differentiation from DPPSC at passages 1, 5 and 10 (N = 3, XX and XY donors). c Fluorochromes image; d Fixed limits summary. e, f CGH from
DPPSC (P10) at day 21 of osteogenic differentiation on biomaterials: Collagen and Titanium carriers (N = 2, XX donors). e Fluorochromes image;
f Fixed limits summary. 47, XXY control samples (labeled in green) and DPPSC samples (labeled in red) were mixed and co-hybridized onto 12 (46,
XY) metaphases in triplicate. A gain in the X or Y chromosome dosage was due to sex differences
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and differentiated on titanium alloy disks with osteogenic
medium for 15 days.
SEM micrographs showed a high-density cell mass on
the surface of the disk for all cell populations, indicating
that the cells adhered and grew favorably (Fig. 6a-c).
Moreover, TI B.DPPSC seemed to cover more surface
than the other cell types (Fig. 6b2). The results of the
ALP assay showed that the ALP activity increased sig-
nificantly over time in TI DPPSC, TI B.DPPSC and TI
SAOS-2, demonstrating that the cells acquired this func-
tional activity during osteoblast differentiation (Fig. 6d).
The behavior of TI DPPSC and TI B.DPPSC was similar;
differences between cell types were only statistically
significant when comparing TI SAOS-2 cells with the
other cell types.
To further characterize the differentiation status of the
cells, the expression levels of several osteogenic and
adhesion markers were evaluated at the end of the
osteogenic differentiation process on TI disks using
SAOS-2 cells for normalization (Fig. 6e-g). Results
showed that TI DPPSC and TI B.DPPSC showed less
expression of the early osteogenic marker RUNX2 than
SAOS-2 and more expression of the osteogenic ad-
vanced markers COL1 and OC, with the highest
expression in TI B.DPPSC (Fig. 6f ). Furthermore, the
analyses of the adhesion markers showed higher expres-
sion of the integrin genes in DPPSC than in SAOS-2
cells (Fig. 6g), confirming the high adhesion potential of
DPPSC to the titanium surface.
Discussion
The third molar represents a very accessible organ, which
is often extracted for dental reasons, and due to its late de-
velopment, allows the presence of progenitor cells. Previ-
ously, we identified DPPSC as a new subpopulation of
DPSC cultivated in a media containing LIF, EGF and
PDGF to maintain their pluripotent state. In addition we
showed that DPPSC are able to differentiate into adult tis-
sues generating all three embryonic germ layers, i.e., endo-
thelial cells, neurons, bone and hepatocyte-like cells [9].
DPMSC and DPPSC are obtained from the same
dental pulp but cultured at different cell densities and
different medium conditions. In this study, the pheno-
typical analysis showed high expression levels of CD29
and CD105 markers, and low expression levels of CD45,
indicating that DPPSC share several similarities with
DPMSC. Nevertheless, DPPSC also express pluripotency
markers such as OCT3/4, NANOG, SOX2 and SSEA4,
Fig. 5 Osteogenic differentiation on Collagen I-based Cell Carrier (CCC). a, b SEM images of differentiated DPPSC adhered on CCC surface (black
arrow). c SEM image of differentiated DPPSC with hydroxyapatite deposition on CCC surface. d SEM image of hydroxyapatite deposition on CCC.
Scale bars: 100 μm (a), 20 μm (b), 10 μm (c), 2 μm (d). e Microanalysis of the CCC surface with atomic concentrations. f RT-PCR gene expression
analysis of differentiation markers (OC, ALP, COL1) and adhesion markers (VCAM1, VLA4) in DPPSC cultured on CCC, DPPSC cultured on 2D (plastic
surface) and SAOS-2 cultured on CCC. GAPDH was used as a housekeeping. g, h Immunohistochemistry of differentiation markers (OC, OPN) in
differentiated DPPSC on CCC. Scale bars: 1000 μm (g1, h1), 400 μm (g2, h2); 200 μm (g3, h3)
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which are indispensable for infinite stem cell division
without affecting differentiation potential. On the other
hand, we consider that pluripotent stem cells have higher
value when testing the differentiation capacity of biomate-
rials, since these cells provide highly undifferentiated cells
which need to be guided merely with the biomaterial.
Hence, we consider that the use of osteoblastic-like cells
to determine the osteogenic capacity of biomaterials is
meaningless compared to the use of pluripotent-like cells.
For all these reasons, we elected DPPSC to perform the
osteogenic differentiations on biomaterials.
To address the requirement to well-characterize the
DPPSC differentiation process, one of the first aims of this
study was to analyze the model system for osteogenesis of
Fig. 6 Osteogenic differentiation on Ti disks. a-c SEM images of the different cells types differentiating on Ti alloy disks. (a) DPPSC, (b) Bone-like
DPPSC, (c) SAOS-2. Stars indicate the Ti surface without cells. Scale Bars: 40 μm (a1, b1, c1), 10 μm (a2, b2, c2). d ALP activity (U/L) of TI DPPSC,
TI B.DPPSC and TI SAOS-2 differentiating on Ti alloy disks at week 1 and 2 (n = 3). e-g RT-PCR (e) and qRT-PCR (f, g) gene expression analysis of
differentiation (RUNX2, COL1 and OC) and adhesion markers (ITGα3 and ITGαV) at second week of cell differentiations on Ti alloy disks (n = 3).
TI SAOS-2 was used for normalization. DPPSC at day 0 of differentiation were used as a negative control and GAPDH was used as housekeeping
gene. *P < 0.05
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this new stem cell population and to establish the expres-
sion profile of bone related genes during their
differentiation process.
In general, our results indicate that the osteogenic dif-
ferentiation of DPPSC is in accordance with the human
osteoblastic development, which can be divided into three
chronologically stages: proliferation, matrix development
and mineralization [24, 25]. Thus, RUNX2 is expressed
during early osteoblast differentiation and is strictly re-
quired for the differentiation and appropriate functioning
of osteoblasts [26]. Here, we found that RUNX2 was
highly expressed during the first week of DPPSC diffe-
rentiation, while the expression levels of pluripotency
markers OCT3/4 and NANOG were reduced, indicating
the end of the proliferation stage. At the second week,
during the extracellular matrix maturation, RUNX2
expression levels were progressively down-regulated while
differentiated cells began to express OC, in agreement
with the reports that RUNX2 is an upstream gene of OC
[25, 26]. Moreover, there was a remarkable peak of OC at
day 15 that indicated an early mineralization of the differ-
entiated DPPSC. On the other hand, by comparing the
gene expression of differentiated DPPSC with differenti-
ated SAOS-2, we can observe that SAOS-2 showed more
expression of the initial osteogenic marker RUNX2 and
similar levels of the advanced marker OC. It was probably
due to the uncontrolled proliferation rate of SAOS-2,
which constantly produces immature cells. SAOS-2 cells
have been frequently used in applied biology since they
are from human origin, they provide an unlimited number
of cells and therefore, they are a fast and a cheap cell
model to test osteogenesis in biomaterials. However, we
consider that the use of pluripotent-like cells that can
potentially differentiate into any lineage assesses better the
role of the biomaterial in the osteogenic differentiation.
Moreover, as DPPSC are in a previous stage of differenti-
ation than SAOS-2 cells, this allows the analysis of the
osteogenic differentiation since the beginning of the
process.
Furthermore, RT-PCR analysis revealed that ALP was
also expressed during the phase of matrix development,
increasing from the first week until the end of the
differentiation. This triggers the mineralization stage,
commonly observed by the production of hydroxyapatite
crystals [27].
At the same time, COLI was detected during the
matrix development until the mineralization stage
indicating that the maturation process of osteoblast-like
cells produced abundant matrix proteins that were de-
posited as osteoid or non-mineralized bone matrix [28].
In addition, results showed very similar osteogenic
expression levels between differentiated DPPSC and
human bone cDNA, in accordance with a previous study
of the osteogenic differentiation of DPPSC, where the
bone-like tissue formed by DPPSCs in 3D were similar
in complexity to human bone tissue [8].
In order to assess the functional activity of bone-like
DPPSC, mineralization and ALP stainings were per-
formed during DPPSC differentiation. By the third week,
both stainings demonstrated an osteoid mineralization
by the accumulation of calcium phosphate in the form
of hydroxyapatite. In addition, protein analysis with high
expression of late osteogenic markers, OC and OPN,
confirmed the osteocyte-like phenotype of DPPSC. In
summary, our results indicated that differentiated
DPPSC show a behavior pattern similar to human
primary osteoblasts [2, 29]. These results support the
capacity of DPPSC to differentiate into bone-like tissue
similar to the traditionally used osteoblastic progenitors.
After analyzing the expression profile of osteogenic
genes during DPPSC differentiation, we examined the
genetic stability of this pluripotent-like stem cell popula-
tion before and after their differentiation process on bio-
materials. The rationale was based on previous studies
that used adult stem cells with genetic stability to assess
the quality and osteogenic capacity of biomaterials [8, 30].
Thus, we analyzed the genetic stability of DPPSC and
SAOS-2 by sCGH, a direct aneuploidy screening that al-
lows the detection of chromosome imbalances generated
by aberrant segregation and structural differences for frag-
ments larger than 10–20 Mb [31]. Our results showed a
normal chromosomal dosage during DPPSC culture ex-
pansion until passage 15. This was also evident at the end
of the differentiation process, both in culture plates and
on biomaterials. Nevertheless, we confirmed some genetic
instability in SAOS-2 cells that have been probably related
to the progression and genesis of osteosarcoma. This low
stability of SAOS-2 could induce phenotype alterations,
aberrations in mitotic processes or lack of growth inhibition
affecting the results of biomaterial testing [5]. Furthermore,
some reports demonstrate a direct correlation between cul-
ture density and the occurrence of DNA damage and gen-
omic alterations during the culture of stem cells in vitro
[32]. These effects are largely caused by the accumulation
of lactic acid in the culture medium and the associated
medium acidification [32, 33]. Here, the particular culture
conditions of DPPSC (medium composition, low serum
levels, low cell confluence before passaging and low cell
culture density) could facilitate the preservation of the gen-
omic stability, making DPPSC a more stable cell model for
testing biomaterials in bone regeneration studies.
It is known that natural materials, metals and synthetic
polymers scaffolds organize stem cells into complex
spatial groupings which mimics native tissue [34]. In this
study, we evaluated the capacity of DPPSC to grow and
differentiate in a natural collagen scaffold (CCC).
Natural biological and mechanical properties of native
collagen provides a bio-mimetic environment for stem
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cells as well as a mechanical support, providing collagen
based biomaterials as commonly used support for cell
culture and tissue engineering [35]. Analysis of the scaf-
fold surface and cell morphology by electron microscopy
emphasized the high affinity of DPPSC to grow in CCC,
the homogenous cell distribution and the high level of
calcification at the final stage of the differentiation. The
expression of osteogenic and adhesion markers in differ-
entiated DPPSC in CCC was comparable to DPPSC
differentiated on culture plates or SAOS-2 cultured in
CCC. Moreover, an immunohistochemistry assay showed
the expression of advanced osteogenic markers (OC,
OPN), corroborating the presence of osteocyte-like cells
and the complete differentiation and biocompatibility of
DPPSC over CCC in vitro.
On the other hand, it has been demonstrated that
metal scaffolds are also suitable for hard-tissue applica-
tions. The loosening of implants from bone tissues has
been a problem in reconstructive surgery and joint
replacement. Brånemark introduced the term “osseointe-
gration” to describe this modality for stable fixation of
titanium to bone tissue [36]. Some studies report that
titanium disks favor the osseointegration, stimulating the
functions of osteoblasts on the surface, such as the
adhesion, proliferation or secretion of specific proteins
composing the matrix [37]. The most common cell
sources used for this propose, are immortalized cell lines
or fibroblasts [38, 39]. However, these cell types show
different characteristics from stem cells involved in bone
regeneration in vivo. Currently, there are few studies
regarding the osseointegration of titanium with stem
cells [40]. Therefore, this study attempts to evaluate
the osteogenic capacity of TI disks with an adult
pluripotent-like stem cell population. For this purpose,
two populations of DPPSC were used: DPPSC and
B.DPPSC. B.DPPSC were DPPSC pre-differentiated for
15 days, when they reached the beginning of the
mineralization stage, corresponding with the peak of OC
expression. This previous differentiation of the cells on
plates before transferring to titanium surfaces can improve
the evaluation of biomaterials, reducing the costs (differ-
entiated cells expand more rapidly and can be cultured at
higher densities) and accelerating the process.
SEM images obtained of TI disks showed a complete
coverage of the surface with all cell types, suggesting a
major density, expansion and adhesion of TI B.DPPSC.
Furthermore, at the second week of differentiation, ALP
concentration increased in all cell types, indicating a
mineralization stage with the development of a calcified
matrix at 15 days of osteogenic induction. On the other
hand, the high ALP activity levels in SAOS-2 could be
explained by some studies which revealed that this
property of SAOS-2 can differ considerably from pri-
mary osteoblasts behavior [2].
At the end of differentiation, TI SAOS-2 cells showed
higher expression of initial markers ALP and RUNX2
and lower expression of advanced markers COL1 or OC.
These results could indicate that this carcinogenic cell
line presents cells in a more immature stage than
DPPSC lines, probably due to their constant and uncon-
trolled proliferation rate. Moreover, we found that the
expression of COL1, the most important protein in the
non-mineralized matrix, was higher in TI B.DPPSC.
Finally, TI DPPSC and TI B.DPPSC demonstrated also a
higher expression of the adhesion markers than TI
SAOS-2 cells, suggesting that DPPSC had a strong
capacity to adhere on titanium surfaces.
Conclusions
In conclusion, these results support the use of DPPSC,
a new pluripotent-like subpopulation of DPSC, as a
good alternative model to evaluate the biocompatibility
and the differentiation capacity of different types of
biomaterials commonly used for bone regeneration
studies. DPPSC showed high osteogenic and adhesion
potential whilst seemed to maintain genetic stability
during culture expansion and differentiation. However,
further studies assessing their genetic stability by means
of more accurate methods and their in vivo biocompati-
bility will be necessary before testing them in clinical
applications.
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Additional file 1: Figure S1. Characterization of undifferentiated
DPPSC. a Cell morphology of DPPSC from passage 10 observed with
optic microscopy. DPPSC are characterized as small-sized cells with large
nuclei and low cytoplasm content. b Immunofluorescence analysis of
OCT3/4-FITC, SSEA4-PE, and Merge. Hoechst (HT) as a nucleus control.
DPPSC were positive for these embryonic markers, and both were located
in the nucleus. c FACS analysis of DPPSC. c1 FACS analysis of membrane
markers: CD105 (92,15%), CD29 (99,63%), CD146 (15,54%) and CD45
(0.04%). c2 FACS analysis of pluripotency nuclear markers: OCT3/4
(76,72%) and NANOG (30,18%). d RT-PCR of OCT3/4, NANOG and SOX2
expresions in DPPSC and DPMSC. e Western Blot analysis of OCT3/4 in
DPPSC and DPMSC at different time points (5, 10 and 15 passages).
GAPDH as a housekeeping. (TIF 1031 kb)
Additional file 2: Figure S2. sCGH summary from SAOS-2 cells at
passage 10. 47, XXY control samples (labelled in green) and SAOS-2 samples
(labelled in red) were co-hybridized onto 46, XY metaphases. (TIF 234 kb)
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